Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: A multicenter IMWG study

S. K. Kumar, M. A. Dimopoulos, E. Kastritis, E. Terpos, H. Nahi, H. Goldschmidt, J. Hillengass, X. Leleu, M. Beksac, M. Alsina, A. Oriol, M. Cavo, E. M. Ocio, M. V. Mateos, E. K. O'Donnell, R. Vij, H. M. Lokhorst, N. W.C.J. Van De Donk, C. Min, T. MarkI. Turesson, M. Hansson, H. Ludwig, S. Jagannath, M. Delforge, C. Kyriakou, P. Hari, U. Mellqvist, S. Z. Usmani, D. Dytfeld, A. Z. Badros, P. Moreau, K. Kim, P. R. Otero, J. H. Lee, C. Shustik, D. Waller, W. J. Chng, S. Ozaki, J. J. Lee, J. De La Rubia, H. S. Eom, L. Rosinol, J. J. Lahuerta, A. Sureda, J. S. Kim, B. G.M. Durie

Research output: Contribution to journal › Article › peer-review

127 Scopus citations

Fingerprint

Dive into the research topics of 'Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: A multicenter IMWG study'. Together they form a unique fingerprint.

Medicine & Life Sciences